Dr. Xiaoyan Zhang obtained her Ph.D. degree from department of Pharmacology and Toxicology in University of Louisville in 2008. Prior to joining the Graduate Program in Louisville, She obtained her M.S. degree from Epidemiology department in Fudan University. Her past research was focused on cancer association with drug metabolizing enzyme N-acetyltransferase and she had eight peer reviewed published papers. While in the Balthasar Lab, Dr. Zhang worked to develop and evaluate of immune complex therapies in rodent models of thrombocytopenic purpura (ITP).